Aligos Therapeutics Inc
Biotechnology
Healthcare
ALGS
6.27 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
4.46
52 week high
45.62
high
5.19
52 week low
4.71
previous Close
4.71
P/E ratio
-2
market cap
139 M
div yield
0
net incoming
-19.26 M
-480.54 %
net profit margin
-1517.65 %
-1994.00 %
operating incoming
-20.13 M
23.79 %
net change in cash
-9.71 M
-146.71 %
cash on hand
35.33 M
-21.74 %
top